/
BCPC
$177.63+$0.49 (+0.28%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$5.7B
32M shares
52-week range
$139.17 – $183.90
86% from low
Sector
CHEMICALS & ALLIED PRODUCTS
Exchange
NASDAQ
CS
Change+$46.31
Balchem Corporation
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
www.balchem.com- Employees
- 1,379
- IPO / List date
- Jun 3, 1986
- HQ
- MONTVALE, NJ
Held by traders on TradeandTell
No one on the platform currently holds BCPC.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 177,000 | $30.0M |
| Bridgewater Associatesas of 2026-03-31 | 17,313 | $2.9M |
Insider activity (SEC Form 4)
Dividend history
TTM yield · 1.47% ($2.62/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-12-23 | $0.9600 | 2026-01-20 |
| 2024-12-26 | $0.8700 | 2025-01-17 |
| 2023-12-26 | $0.7900 | 2024-01-19 |
Stock splits
| Execution date | Ratio |
|---|---|
| 2010-01-21 | 3-for-2 |
| 2007-01-22 | 3-for-2 |
Recent trades on TradeandTell
No one on the platform has traded BCPC yet.
